Terms: = Skin cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Prognosis
214 results:
1. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
[TBL] [Abstract] [Full Text] [Related]
2. Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma.
Zhang W; Wang S
Melanoma Res; 2024 Jun; 34(3):215-224. PubMed ID: 38364052
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
[TBL] [Abstract] [Full Text] [Related]
4. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
[TBL] [Abstract] [Full Text] [Related]
5. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
[TBL] [Abstract] [Full Text] [Related]
6. Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness.
Cismas S; Pasca S; Crudden C; Trocoli Drakensjo I; Suleymanova N; Zhang S; Gebhard B; Song D; Neo S; Shibano T; Smith TJ; Calin GA; Girnita A; Girnita L
Mol Cancer Res; 2023 Dec; 21(12):1288-1302. PubMed ID: 37584671
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Features of Li-Fraumeni Syndrome in Korea.
Song R; Kong SY; Choi W; Lee EG; Woo J; Han JH; Lee S; Kang HS; Jung SY
Cancer Res Treat; 2024 Jan; 56(1):334-341. PubMed ID: 37562436
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Aluminium phthalocyanine nanoconjugate on melanoma stem cells.
Mkhobongo B; Chandran R; Abrahamse H
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):334-345. PubMed ID: 37455406
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and pathological features of second primary neoplasms arising in head and neck reconstructive skin flaps.
Eguchi K; Kobayashi K; Honma Y; Ryo E; Sakyo A; Yokoyama K; Watanabe T; Aihara Y; Sakai A; Matsumoto Y; Sakai T; Omura G; Yatabe Y; Yoshimoto S; Mori T
Sci Rep; 2023 Jul; 13(1):11214. PubMed ID: 37433786
[TBL] [Abstract] [Full Text] [Related]
10. KRT80 expression works as a biomarker and a target for differentiation in gastric cancer.
Shi KH; Xue H; Zhao EH; Xiao LJ; Sun HZ; Zheng HC
Histol Histopathol; 2024 Jan; 39(1):117-130. PubMed ID: 37129345
[TBL] [Abstract] [Full Text] [Related]
11. Association of Merkel Cell Polyomavirus Status With p53, RB1, and PD-L1 Expression and Patient prognosis in Merkel Cell Carcinomas: Clinical, Morphologic, and Immunohistochemical Evaluation of 17 Cases.
Öğüt B; Bayram EK; İnan MA; Kestel S; Erdem Ö
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):371-378. PubMed ID: 37126387
[TBL] [Abstract] [Full Text] [Related]
12. Disruptive and Truncating tp53 Mutations Are Associated with African-Ancestry and Worse prognosis in Brazilian Patients with Lung Adenocarcinoma.
Cavagna RO; Pinto IA; Escremim de Paula F; Berardinelli GN; Sant'Anna D; Santana I; da Silva VD; Da Silva ECA; Miziara JE; Mourão Dias J; Antoniazzi A; Jacinto A; De Marchi P; Molina-Vila MA; Ferro Leal L; Reis RM
Pathobiology; 2023; 90(5):344-355. PubMed ID: 37031678
[TBL] [Abstract] [Full Text] [Related]
13. miRNAs as potential game-changers in melanoma: A comprehensive review.
Abd-Allah GM; Ismail A; El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Abdelmaksoud NM; Salman A; Elkhawaga SY; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154424. PubMed ID: 36989843
[TBL] [Abstract] [Full Text] [Related]
14. Challenges in the diagnosis and treatment of the malignant adnexal neoplasms of the head and neck.
Wierzbicka M; Kraiński P; Bartochowska A
Curr Opin Otolaryngol Head Neck Surg; 2023 Apr; 31(2):134-145. PubMed ID: 36912226
[TBL] [Abstract] [Full Text] [Related]
15. Locally advanced choroidal melanoma with favorable molecular prognosis - case report.
Bălăşoiu AT; Ştefănescu-Dima AŞ; Bălăşoiu M; Ciurea RN; Muraru A; Dan AO; Simionescu CE
Rom J Morphol Embryol; 2022; 63(4):645-652. PubMed ID: 36808200
[TBL] [Abstract] [Full Text] [Related]
16. MARCO is a potential prognostic and immunotherapy biomarker.
Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
[TBL] [Abstract] [Full Text] [Related]
17. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract] [Full Text] [Related]
18. Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports.
Ko YL; Kumar V; Lippert J; Diaz-Cano S; Skordilis K; Kimpel O; Kircher S; Asia M; Elhassan YS; Altieri B; Ronchi CL
BMC Endocr Disord; 2023 Jan; 23(1):4. PubMed ID: 36604647
[TBL] [Abstract] [Full Text] [Related]
19. A nomogram combining clinical factors and biomarkers for predicting the recurrence of high-risk cutaneous squamous cell carcinoma.
Oh Y; Zheng Z; Kim KY; Xu X; Pei M; Oh B; Kim SK; Chung KY; Roh MR
BMC Cancer; 2022 Nov; 22(1):1126. PubMed ID: 36324094
[TBL] [Abstract] [Full Text] [Related]
20. Primary cutaneous SMARCA4-deficient undifferentiated malignant neoplasm: first two cases with clinicopathologic and molecular comparison to eight visceral counterparts.
Russell-Goldman E; MacConaill L; Hanna J
Mod Pathol; 2022 Dec; 35(12):1821-1828. PubMed ID: 36085356
[TBL] [Abstract] [Full Text] [Related]
[Next]
